SK Biopharmaceuticals files US NDA for liquid Cenobamate
--------------------------------------------------------------------
Source: The Korea Herald
Published: 2026-04-01 15:02 UTC+10:00
Section: All News
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Food & Agriculture, Drugs, World News
--------------------------------------------------------------------
Snippet:
SK Biopharmaceuticals announced that it submitted a new drug application to the US Food and Drug Administration for the oral suspension formulation of its epilepsy drug Cenobamate.
--------------------------------------------------------------------